|
CONDENSED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
121 Months Ended |
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2013
|
| Operating expenses: |
|
|
|
|
|
|
|
| General and administrative |
$ 1,035 |
$ 649 |
$ 2,553 |
$ 2,072 |
$ 3,662 |
$ 3,953 |
$ 15,765 |
| Research and development |
760 |
686 |
2,788 |
2,268 |
2,733 |
2,922 |
16,712 |
| Research and development grant received |
|
|
|
|
0 |
0 |
(489) |
| Total operating expenses |
1,795 |
1,335 |
5,341 |
4,340 |
6,395 |
6,875 |
31,988 |
| Loss from operations |
(1,795) |
(1,335) |
(5,341) |
(4,340) |
(6,395) |
(6,875) |
(31,988) |
| Other income (expense): |
|
|
|
|
|
|
|
| Financing cost |
|
|
|
|
0 |
0 |
(519) |
| (Loss) gain on change in fair value of warrant derivative liability |
0 |
330 |
0 |
1,096 |
1,096 |
(50) |
86 |
| Interest (expense) income, net |
2 |
0 |
3 |
(2) |
(3) |
5 |
36 |
| Loss before provision for income taxes |
(1,793) |
(1,005) |
(5,338) |
(3,246) |
(5,302) |
(6,920) |
(32,385) |
| Provision for income taxes |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Net loss |
$ (1,793) |
$ (1,005) |
$ (5,338) |
$ (3,246) |
$ (5,302) |
$ (6,920) |
$ (32,385) |
| Net loss per common share, basic and diluted (in dollars per share) |
$ (0.05) |
$ (0.04) |
$ (0.18) |
$ (0.14) |
$ (0.21) |
$ (0.32) |
|
| Weighted average shares outstanding (in shares) |
32,693,788 |
25,364,457 |
29,589,182 |
23,995,394 |
24,816,481 |
21,805,211 |
|